AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10621518 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help programs
Number of subjects: 41
Study 10621518 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based programs
Number of subjects: 41
Study 10621518 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 41
Study 8751544 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel (135 or 175 mg/m2) over 3 hr followed by cisplatin (75 mg/m2)
Number of subjects: 38
Study 1910100 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate postoperative nasojejunal feeding with full strength Osmolite solution for 56 hours (n = 16)
Number of subjects: 32
Study 1910100 — intervention group
Group type: COMPARATOR
Intervention: Routine postoperative hypocaloric fluids and gradual reintroduction of diet (n = 16)
Number of subjects: 32
Study 1910100 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate postoperative nasojejunal feeding
Number of subjects: 32
Study 1910100 — intervention group
Group type: COMPARATOR
Intervention: Routine postoperative hypocaloric fluids
Number of subjects: 32
Study 1910100 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate postoperative nasojejunal feeding and Routine postoperative hypocaloric fluids
Number of subjects: 32
Study 6883850 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold application
Number of subjects: 36
Study 6883850 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat application
Number of subjects: 36
Study 29384426 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n = 27)
Number of subjects: 55
Study 29384426 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 28)
Number of subjects: 55
Study 29395424 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular injections of allogeneic MSCs
Number of subjects: 32
Study 29395424 — intervention group
Group type: COMPARATOR
Intervention: Autogenous concentrated bone marrow aspirate
Number of subjects: 32
Study 29395424 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical limb perfusion assessment
Number of subjects: 32
Study 29395424 — intervention group
Group type: EXPERIMENTAL
Intervention: All-cause mortality, need for amputation revision, gangrene incidence
Number of subjects: 32
Study 25236322 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin phosphate
Number of subjects: 240
Study 25236322 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide
Number of subjects: 240
Study 25236322 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of clindamycin phosphate plus benzoyl peroxide
Number of subjects: 240
Study 25236322 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 240
Study 24451290 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-chamber pacing (DDDR)
Number of subjects: 0
Study 24451290 — intervention group
Group type: COMPARATOR
Intervention: Single-lead atrial pacing (AAIR)
Number of subjects: 0
Study 22705129 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed Tomography Angiography (CTA)
Number of subjects: 125
Study 22705129 — intervention group
Group type: EXPERIMENTAL
Intervention: T2-weighted MRI
Number of subjects: 125
Study 22705129 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Angiography (MRA)
Number of subjects: 125
Study 22705129 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging (MRI)
Number of subjects: 125
Study 21290834 — intervention group
Group type: EXPERIMENTAL
Intervention: Pricking blood along meridians combined with electroacupuncture
Number of subjects: 100
Study 21290834 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture (control group)
Number of subjects: 100
Study 17141470 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoral vertical ramus osteotomy (IVRO)
Number of subjects: 30
Study 17141470 — intervention group
Group type: EXPERIMENTAL
Intervention: Obwegeser method (Ob)
Number of subjects: 30
Study 17141470 — intervention group
Group type: COMPARATOR
Intervention: Obwegeser-Dal Pont method (ODP)
Number of subjects: 30
Study 16297756 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol infusion with a preset target concentration of 2.5 microg/mL until sedation level 3 was achieved.
Number of subjects: 150
Study 16297756 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 150
Study 12905798 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulatory pH monitoring in elderly patients with GERD
Number of subjects: 72
Study 12905798 — intervention group
Group type: COMPARATOR
Intervention: Control group (patients less than 65 years old)
Number of subjects: 72
Study 12905798 — intervention group
Group type: EXPERIMENTAL
Intervention: Elderly patients with GERD
Number of subjects: 72
Study 9704200 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylbutazone 10 mg/kg intramuscularly
Number of subjects: 29
Study 9704200 — intervention group
Group type: COMPARATOR
Intervention: Control injection (vehicle-containing local anaesthetic)
Number of subjects: 29
Study 8539544 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfamethoxazole-trimethoprim (SMX-TMP) 400/80 mg b.i.d.
Number of subjects: 94
Study 8539544 — intervention group
Group type: COMPARATOR
Intervention: Aerosolized pentamidine (AP) 60 mg every 2nd week
Number of subjects: 94
Study 31900813 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication providing a 'cure' with flu-like symptoms
Number of subjects: 454
Study 31900813 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication providing a 'remission' labeled as 'cure' with flu-like symptoms
Number of subjects: 454
Study 31900813 — intervention group
Group type: COMPARATOR
Intervention: Medication providing a 'remission' without labeling as 'cure'
Number of subjects: 454
Study 31687955 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin (8-10 μg/kg*min)
Number of subjects: 72
Study 31687955 — intervention group
Group type: COMPARATOR
Intervention: Control group (no nitroglycerin)
Number of subjects: 72
Study 27559692 — intervention group
Group type: EXPERIMENTAL
Intervention: E-cigarette administration
Number of subjects: 9
Study 27559692 — intervention group
Group type: COMPARATOR
Intervention: Tobacco cigarette administration
Number of subjects: 9
Study 26046707 — intervention group
Group type: EXPERIMENTAL
Intervention: iDesign
Number of subjects: 30
Study 26046707 — intervention group
Group type: COMPARATOR
Intervention: WaveScan
Number of subjects: 30
Study 23482083 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25-0.8 Hz pulsed RF EMF exposure
Number of subjects: 16
Study 23482083 — intervention group
Group type: COMPARATOR
Intervention: Sham exposure
Number of subjects: 16
Study 20848538 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic assessment
Number of subjects: 24
Study 20848538 — intervention group
Group type: EXPERIMENTAL
Intervention: CDAI scores
Number of subjects: 24
Study 20848538 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean CRP and ESR values
Number of subjects: 24
Study 19194270 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-2 therapy
Number of subjects: 92
Study 19194270 — intervention group
Group type: COMPARATOR
Intervention: Antiretroviral therapy alone
Number of subjects: 92
Study 17533020 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin, 40 mg/d for 6 weeks
Number of subjects: 0
Study 17533020 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil, 600 mg twice daily for 6 weeks
Number of subjects: 0
Study 17533020 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15576517 — intervention group
Group type: EXPERIMENTAL
Intervention: Valdecoxib 40 mg
Number of subjects: 51
Study 15576517 — intervention group
Group type: COMPARATOR
Intervention: Oxycodone 10 mg with acetaminophen 650 mg
Number of subjects: 51
Study 11344672 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP at 0.2 kPa
Number of subjects: 20
Study 11344672 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP at 0.3 kPa
Number of subjects: 20
Study 11344672 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP at 0.4 kPa
Number of subjects: 20
Study 11344672 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP levels (0.2, 0.3, 0.4 kPa)
Number of subjects: 20
Study 9741224 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (EPO) 150 units/kg per day
Number of subjects: 40
Study 9741224 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 8306408 — intervention group
Group type: EXPERIMENTAL
Intervention: AdVP (doxorubicin, vincristine, and prednisolone)
Number of subjects: 198
Study 8306408 — intervention group
Group type: EXPERIMENTAL
Intervention: L-AdVP (doxorubicin, vincristine, prednisolone, and L-asparaginase)
Number of subjects: 198
Study 8306408 — intervention group
Group type: COMPARATOR
Intervention: L-AdVP
Number of subjects: 198
Study 2647291 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body hyperthermia (WBH) at 40.5 degrees C for 75 min
Number of subjects: 17
Study 2647291 — intervention group
Group type: EXPERIMENTAL
Intervention: Human lymphoblastoid interferon (IFN) administered i.m. at doses of 1 x 10(6) units/m2, 3 x 10(6) units/m2, and 10 x 10(6) units/m2
Number of subjects: 17
Study 2647291 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of WBH and human lymphoblastoid IFN
Number of subjects: 17
Study 2647291 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance therapy with IFN
Number of subjects: 17
Study 52367 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy (quintuple drug regimen: mechloretamine, adriamycin, bleomycin, vincristine, and prednisone)
Number of subjects: 0
Study 52367 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy (quintuple drug regimen)
Number of subjects: 0
Study 52367 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination chemotherapy followed by involved field irradiation
Number of subjects: 0
Study 52367 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide, vincristine, and prednisone (CVP)
Number of subjects: 0
Study 52367 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy plus CVP
Number of subjects: 0
Study 29886347 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led group treatment based on CBT-I (n=90)
Number of subjects: 165
Study 29886347 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (n=75)
Number of subjects: 165
Study 28756415 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT)
Number of subjects: 211
Study 28756415 — intervention group
Group type: EXPERIMENTAL
Intervention: Return-to-work intervention (RTW-I)
Number of subjects: 211
Study 28756415 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined CBT and RTW-I (COMBO)
Number of subjects: 211
Study 28756415 — intervention group
Group type: COMPARATOR
Intervention: All treatments (CBT, RTW-I, COMBO)
Number of subjects: 211
Study 25135867 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin users
Number of subjects: 543
Study 25135867 — intervention group
Group type: COMPARATOR
Intervention: Non-users
Number of subjects: 543
Study 23914908 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Motivational Interviewing (MI)
Number of subjects: 400
Study 23914908 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Education (HE)
Number of subjects: 400
Study 21654341 — intervention group
Group type: EXPERIMENTAL
Intervention: Assisted countermovement jump training (n = 9)
Number of subjects: 28
Study 21654341 — intervention group
Group type: EXPERIMENTAL
Intervention: Resisted countermovement jump training (n = 11)
Number of subjects: 28
Study 21654341 — intervention group
Group type: COMPARATOR
Intervention: Free countermovement jump training (n = 8)
Number of subjects: 28
Study 18486782 — intervention group
Group type: EXPERIMENTAL
Intervention: HemCon Dental Dressing (HDD)
Number of subjects: 0
Study 18486782 — intervention group
Group type: COMPARATOR
Intervention: Control (standard treatment)
Number of subjects: 0
Study 17000189 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant stanol-enriched margarine with lipid-lowering dietary intervention
Number of subjects: 20
Study 17000189 — intervention group
Group type: COMPARATOR
Intervention: Standard care (margarine without plant stanols)
Number of subjects: 20
Study 17000189 — intervention group
Group type: COMPARATOR
Intervention: Both groups (plant stanol and control)
Number of subjects: 20
Study 14558436 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg manidipine dihydrochloride
Number of subjects: 18
Study 14558436 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg delapril hydrochloride
Number of subjects: 18
Study 14558436 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous administration of 10 mg manidipine and 30 mg delapril
Number of subjects: 18
Study 10929148 — intervention group
Group type: EXPERIMENTAL
Intervention: Amodiaquine
Number of subjects: 246
Study 10929148 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfadoxine/pyrimethamine
Number of subjects: 246
Study 10929148 — intervention group
Group type: EXPERIMENTAL
Intervention: Amodiaquine and sulfadoxine/pyrimethamine
Number of subjects: 246
Study 8811399 — intervention group
Group type: EXPERIMENTAL
Intervention: High expressed emotion (EE)
Number of subjects: 10
Study 8811399 — intervention group
Group type: EXPERIMENTAL
Intervention: Low expressed emotion (EE)
Number of subjects: 10
Study 8811399 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional exhaustion, depersonalisation, and GHQ levels
Number of subjects: 10
Study 8811399 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal accomplishment and job satisfaction
Number of subjects: 10
Study 8811399 — intervention group
Group type: EXPERIMENTAL
Intervention: High EE interviews
Number of subjects: 10
Study 1568861 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 31
Study 1568861 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 3880714 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 mg penicillamine
Number of subjects: 53
Study 3880714 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg penicillamine
Number of subjects: 53
Study 31291305 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc Methionine (ZM)
Number of subjects: 1482
Study 31291305 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc Sulfate (ZS)
Number of subjects: 1482
Study 31291305 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1482
Study 29969138 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-Supported Advance Care Planning (NSACP) intervention
Number of subjects: 50
Study 29969138 — intervention group
Group type: COMPARATOR
Intervention: Comparison condition
Number of subjects: 50
Study 27344823 — intervention group
Group type: EXPERIMENTAL
Intervention: He's fire needle therapy applied for 8 weeks
Number of subjects: 50
Study 27344823 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 50
Study 24660971 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity groups
Number of subjects: 277
Study 24660971 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 277
Study 22420830 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.06 mg.kg(‐1) rocuronium priming followed by 0.54 mg.kg(‐1) rocuronium
Number of subjects: 92
Study 22420830 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg.kg(‐1) magnesium sulphate
Number of subjects: 92
Study 22420830 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of magnesium sulphate and rocuronium priming
Number of subjects: 92
Study 22420830 — intervention group
Group type: COMPARATOR
Intervention: 0.6 mg.kg(‐1) rocuronium
Number of subjects: 92
Study 20107199 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomato juice containing 90 mmol Na (B)
Number of subjects: 35
Study 20107199 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomato juice containing 140 mmol Na (C)
Number of subjects: 35
Study 17660483 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral roflumilast 500 mug, once daily
Number of subjects: 12
Study 17660483 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant administration of roflumilast and budesonide
Number of subjects: 12
Study 17660483 — intervention group
Group type: COMPARATOR
Intervention: Roflumilast AUC and C(max)
Number of subjects: 12
Study 17660483 — intervention group
Group type: COMPARATOR
Intervention: Roflumilast N‐oxide and budesonide AUC and C(max)
Number of subjects: 12
Study 17660483 — intervention group
Group type: EXPERIMENTAL
Intervention: Coadministration of roflumilast and budesonide
Number of subjects: 12
Study 15465743 — intervention group
Group type: EXPERIMENTAL
Intervention: Soygerm (1.1 micromol/kg body weight)
Number of subjects: 25
Study 15465743 — intervention group
Group type: COMPARATOR
Intervention: Novasoy isoflavone extract (1.5 micromol/kg)
Number of subjects: 25
Study 15465743 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented soygerm (3.3 micromol/kg)
Number of subjects: 25
Study 15465743 — intervention group
Group type: EXPERIMENTAL
Intervention: Low daidzein degradation phenotype
Number of subjects: 25
Study 11408982 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalteparin 200 units/kg given subcutaneously on the two mornings prior to the procedure and restarted 12-24 hours after the procedure until INR was therapeutic.
Number of subjects: 24
Study 11408982 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalteparin
Number of subjects: 24
Study 9589648 — intervention group
Group type: EXPERIMENTAL
Intervention: Miglitol 25 mg TID
Number of subjects: 411
Study 9589648 — intervention group
Group type: EXPERIMENTAL
Intervention: Miglitol 50 mg TID
Number of subjects: 411
Study 9589648 — intervention group
Group type: EXPERIMENTAL
Intervention: Glyburide (titrated dose)
Number of subjects: 411
Study 9589648 — intervention group
Group type: COMPARATOR
Intervention: Placebo TID
Number of subjects: 411
Study 7978718 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral estradiol 1 mg/d
Number of subjects: 13
Study 7978718 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral estradiol 2 mg/d
Number of subjects: 13
Study 7978718 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 2521816 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitor (cilazapril)
Number of subjects: 21
Study 2521816 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 31393029 — intervention group
Group type: EXPERIMENTAL
Intervention: MI‐SI plus treatment as usual (TAU)
Number of subjects: 0
Study 31393029 — intervention group
Group type: EXPERIMENTAL
Intervention: MI‐SI‐R plus treatment as usual (TAU)
Number of subjects: 0
Study 31393029 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU) alone
Number of subjects: 0
Study 31676505 — intervention group
Group type: EXPERIMENTAL
Intervention: Crisis Intervention Team (CIT) model
Number of subjects: 0
Study 29768332 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized arch support insoles for 12 weeks
Number of subjects: 52
Study 27299675 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 mg or 25 mg once daily)
Number of subjects: 6185
Study 27299675 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6185
Study 25110374 — intervention group
Group type: EXPERIMENTAL
Intervention: Three rounds of azithromycin mass drug administration (MDA)
Number of subjects: 0
Study 25110374 — intervention group
Group type: COMPARATOR
Intervention: One round of azithromycin mass drug administration (MDA)
Number of subjects: 0
Study 22468770 — intervention group
Group type: EXPERIMENTAL
Intervention: Surrogate Decision Making Confidence Scale
Number of subjects: 58
Study 22468770 — intervention group
Group type: EXPERIMENTAL
Intervention: Values of Life‐Sustaining Treatment Outcomes
Number of subjects: 58
Study 22468770 — intervention group
Group type: EXPERIMENTAL
Intervention: Goals of Care documents
Number of subjects: 58
Study 22468770 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyad congruence in values for life‐sustaining treatment
Number of subjects: 58
Study 22468770 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyad congruence in goals of care
Number of subjects: 58
Study 20592248 — intervention group
Group type: EXPERIMENTAL
Intervention: Hematopoietic stem cell transplantation (HSCT)
Number of subjects: 297
Study 20592248 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy only
Number of subjects: 297
Study 17547539 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA group (BSF plus fish oil DHA 200 mg)
Number of subjects: 144
Study 17547539 — intervention group
Group type: COMPARATOR
Intervention: Control group (combined groups not receiving DHA: BS and BSF)
Number of subjects: 144
Study 16287768 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision-support tool (Couplers)
Number of subjects: 1902
Study 16287768 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1902
Study 11916809 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% levobupivacaine
Number of subjects: 50
Study 11916809 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine
Number of subjects: 50
Study 10803133 — intervention group
Group type: EXPERIMENTAL
Intervention: Helioseal F
Number of subjects: 58
Study 10803133 — intervention group
Group type: EXPERIMENTAL
Intervention: Fissurit F
Number of subjects: 58
Study 10803133 — intervention group
Group type: EXPERIMENTAL
Intervention: Rubber dam isolation
Number of subjects: 58
Study 10803133 — intervention group
Group type: COMPARATOR
Intervention: Cotton roll isolation
Number of subjects: 58
Study 7673021 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy with bromodeoxyuridine (BrdUrd) 0.8 g/m2 per day for 4 days of each of 3 weeks
Number of subjects: 72
Study 7673021 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone (37.5 Gy in 15 fractions of 2.5 Gy)
Number of subjects: 72
Study 7673021 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment arms
Number of subjects: 72
Study 2041549 — intervention group
Group type: EXPERIMENTAL
Intervention: GM-1 ganglioside (100 mg intravenously per day for 18 to 32 doses)
Number of subjects: 34
Study 2041549 — intervention group
Group type: COMPARATOR
Intervention: Placebo (intravenously per day for 18 to 32 doses)
Number of subjects: 34
Study 2041549 — intervention group
Group type: EXPERIMENTAL
Intervention: GM-1 ganglioside
Number of subjects: 34
Study 2041549 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 6102458 — intervention group
Group type: EXPERIMENTAL
Intervention: Butaperazine maleate
Number of subjects: 24